Ascendis Pharma
VerifiedAscendis Pharma is applying its innovative TransCon technologies to build a leading, fully integrated biopharmaceutical company focused on making a meaningful.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
€7.4b (Public information from May 2024)
Share price
$133.46001 ASND
Company register number HRB 337385 (Mannheim)
Gentofte Municipality Capital Region of Denmark (HQ)